Next Article in Journal
Medical and Nonmedical Information during Multidisciplinary Team Meetings in Cancer Care
Previous Article in Journal
Evolution of Public Health Human Papillomavirus Immunization Programs in Canada
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 18
Issue s2
10.3390/curroncol18120004
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

The Significance of Progressionfree Survival as an Endpoint in Evaluating the Therapeutic Value of Antineoplastic Agents

by
J.A. Maroun
Curr. Oncol. 2011, 18(s2), 3-4; https://doi.org/10.3390/curroncol18120004
Submission received: 4 July 2011 / Revised: 14 August 2011 / Accepted: 10 September 2011 / Published: 1 October 2011
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

In the last decade, thanks to the development of new and effective cytotoxic and biologic agents, significant progress has been achieved in the treatment of various forms of cancer. [...]

Share and Cite

MDPI and ACS Style

Maroun, J.A. The Significance of Progressionfree Survival as an Endpoint in Evaluating the Therapeutic Value of Antineoplastic Agents. Curr. Oncol. 2011, 18, 3-4. https://doi.org/10.3390/curroncol18120004

AMA Style

Maroun JA. The Significance of Progressionfree Survival as an Endpoint in Evaluating the Therapeutic Value of Antineoplastic Agents. Current Oncology. 2011; 18(s2):3-4. https://doi.org/10.3390/curroncol18120004

Chicago/Turabian Style

Maroun, J.A. 2011. "The Significance of Progressionfree Survival as an Endpoint in Evaluating the Therapeutic Value of Antineoplastic Agents" Current Oncology 18, no. s2: 3-4. https://doi.org/10.3390/curroncol18120004

APA Style

Maroun, J. A. (2011). The Significance of Progressionfree Survival as an Endpoint in Evaluating the Therapeutic Value of Antineoplastic Agents. Current Oncology, 18(s2), 3-4. https://doi.org/10.3390/curroncol18120004

Article Metrics

Back to TopTop